Phase-III trial of Oxford vaccine to begin in Pune next week

Phase-III trial of Oxford vaccine to begin in Pune next week The SII has partnered with British-Swedish pharma company AstraZeneca for manufacturing the COVID-19 vaccine candidate, developed by the University of Oxford. https://ift.tt/eA8V8J

No comments:

Post a Comment